e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Post-transplant complications: from pathogenesis to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Posaconazole levels in the bronchoalveolar lavage from lung transplant recipients
L. Thakuria, K. Packwood, S. Soresi, K. Habibi-Parker, H. Lyster, H. Lamba, A. Firouzi, P. Rogers, M. Chibvuri, M. Carby, A. Simon, N. Leaver, A. Reed (Harefield, Hoddesdon, United Kingdom)
Source:
International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Session:
Post-transplant complications: from pathogenesis to treatment
Session type:
Poster Discussion
Number:
3315
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Thakuria, K. Packwood, S. Soresi, K. Habibi-Parker, H. Lyster, H. Lamba, A. Firouzi, P. Rogers, M. Chibvuri, M. Carby, A. Simon, N. Leaver, A. Reed (Harefield, Hoddesdon, United Kingdom). Posaconazole levels in the bronchoalveolar lavage from lung transplant recipients. Eur Respir J 2014; 44: Suppl. 58, 3315
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Eosinophilia predicts poor outcome after lung transplantation
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
BAL neutrophilia increases mortality in lung transplant patients despite azithromycin treatment
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
Heterogeneity within chronic lung allograft dysfunction: A BAL analysis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Azole plasma concentrations in lung transplant recipients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Colonization of bacteria after lung transplantation in cystic fibrosis (CF) patients occurs early but does not impact survival
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
Non-tuberculous mycobacterium infection in lung transplant recipients
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Antibodies against
P. aeruginosa
exoproteases in BAL from lung transplant recipients
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients
Source: Eur Respir J 2002; 19: 472-478
Year: 2002
Serum cytokines patterns in lung transplant recipients
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015
Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Nocardia infections in lung transplant recipients (LxTR)
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Relation of sputum and BAL neutrophils to the development of Chronic Lung Allograft Dysfunction after lung transplantation
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Malignant tumours in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
M2 polarized macrophages in bronchoalveolar lavage of lung transplant recipients
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept